Abstract
Experiments were conducted to elucidate the mechanisms of action of endothelins in facilitating neurotransmission to the rat isolated vas deferens. Endothelin-1 and endothelin-3 potentiated field stimulation-induced contractions and those evoked by ATP and alpha, beta-methylene ATP. Responses to noradrenaline were unaffected. The C-terminal hexapeptide, endothelin-(16-21) was without effect on neurotransmission. The facilitation by endothelin-1 of responses to trains of stimulation (10 Hz for 10 s) was absent in the presence of the P2-purinoceptor antagonist, suramin, in concentrations which antagonised the contractile effects of alpha, beta-methylene ATP, but not those of noradrenaline. Suramin did not affect 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)- phenyl]-3-pyridine carboxylic acid methyl ester (Bay K 8644)-induced potentiation of contractions in response to field stimulation. These results support the hypothesis that endothelin-induced facilitation of sympathetic neurotransmission to the vas deferens is due to potentiation of the postjunctional effects of the co-transmitter, ATP, acting at P2X-purinoceptors, and indicate that this effect is mediated through actions at endothelin receptors that are not of the...Continue Reading
References
Jan 1, 1992·Life Sciences·M IharaM Yano
Mar 1, 1992·British Journal of Pharmacology·N J MallardT L Spriggs
Sep 10, 1992·European Journal of Pharmacology·N MallardB Spriggs
Jul 1, 1992·Peptides·M V DonosoJ P Huidobro-Toro
Feb 14, 1991·European Journal of Pharmacology·T Shoji, K Goto
Jan 1, 1991·Journal of Cardiovascular Pharmacology·P Y WongD N Qin
Oct 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·S Télémaque, P D'Orléans-Juste
Mar 25, 1991·Biochemical and Biophysical Research Communications·D L WilliamsB V Clineschmidt
Aug 21, 1990·European Journal of Pharmacology·N P WiklundL E Gustafsson
Sep 28, 1990·Biochemical and Biophysical Research Communications·K OkadaM Yano
Jun 1, 1990·Archives of Biochemistry and Biophysics·R C BatemanL B Hersh
Mar 31, 1988·Nature·M YanagisawaT Masaki
Jan 1, 1989·Journal of Cardiovascular Pharmacology·A P DavenportM J Brown
Jul 4, 1989·European Journal of Pharmacology·C A MaggiA Meli
Aug 29, 1989·European Journal of Pharmacology·T C MajorD G Taylor
Feb 27, 1989·Neuroscience Letters·C R JonesM Mohr
Dec 12, 1989·European Journal of Pharmacology·C A MaggiA Meli
Mar 17, 1987·European Journal of Pharmacology·N I Amobi, I C Smith
Feb 1, 1988·British Journal of Pharmacology·P M Dunn, A G Blakeley
Apr 1, 1971·Acta Physiologica Scandinavica·G Swedin
Jan 1, 1993·Journal of Cardiovascular Pharmacology·J R Wu-WongT J Opgenorth
Mar 11, 1994·European Journal of Pharmacology·S Ventura, J N Pennefather
Oct 1, 1993·British Journal of Pharmacology·T D WarnerJ R Vane
Jul 1, 1993·British Journal of Pharmacology·A EglezosJ Mizrahi
Citations
Sep 1, 1996·General Pharmacology·A KumarA Gulati
Feb 5, 1999·European Journal of Pharmacology·A FilippelliF Rossi
Sep 1, 2000·Regulatory Peptides·S VenturaJ N Pennefather
Aug 24, 1999·British Journal of Pharmacology·W A LauF J Mitchelson
Sep 13, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuko TsuchiyamaIchiro Nishio
Jan 2, 2007·European Journal of Pharmacology·Man ChengWing-Tai Cheung
Sep 29, 2011·Neurourology and Urodynamics·José Luis ArteagaMedardo Hernández
Mar 21, 2007·European Journal of Pharmacology·Poungrat PakdeechoteWilliam R Dunn
Feb 10, 2017·American Journal of Physiology. Renal Physiology·Eman Y GoharDavid M Pollock
Aug 19, 2007·Neurourology and Urodynamics·K-E Andersson
Sep 4, 2004·Journal of Receptor and Signal Transduction Research·Makoto YonoRobert M Weiss
Oct 20, 2001·Journal of Applied Physiology·D L KelloggP E Pérgola
Jan 1, 1997·Life Sciences·D C WanW T Cheung